Cargando…
Patients taking angiotensin-converting enzyme inhibitors/angiotensin II type I receptor blockers: higher risks of severe acute respiratory syndrome coronavirus 2 infection but milder clinical manifestations?
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7647493/ https://www.ncbi.nlm.nih.gov/pubmed/32804730 http://dx.doi.org/10.1097/CM9.0000000000000996 |
_version_ | 1783606919376666624 |
---|---|
author | Deng, Jie-Lin Jiang, Yun-Qiu Guo, Yan-Kai Li, Hong-Liang |
author_facet | Deng, Jie-Lin Jiang, Yun-Qiu Guo, Yan-Kai Li, Hong-Liang |
author_sort | Deng, Jie-Lin |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7647493 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-76474932020-11-20 Patients taking angiotensin-converting enzyme inhibitors/angiotensin II type I receptor blockers: higher risks of severe acute respiratory syndrome coronavirus 2 infection but milder clinical manifestations? Deng, Jie-Lin Jiang, Yun-Qiu Guo, Yan-Kai Li, Hong-Liang Chin Med J (Engl) Editorials Lippincott Williams & Wilkins 2020-11-20 2020-08-13 /pmc/articles/PMC7647493/ /pubmed/32804730 http://dx.doi.org/10.1097/CM9.0000000000000996 Text en Copyright © 2020 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 |
spellingShingle | Editorials Deng, Jie-Lin Jiang, Yun-Qiu Guo, Yan-Kai Li, Hong-Liang Patients taking angiotensin-converting enzyme inhibitors/angiotensin II type I receptor blockers: higher risks of severe acute respiratory syndrome coronavirus 2 infection but milder clinical manifestations? |
title | Patients taking angiotensin-converting enzyme inhibitors/angiotensin II type I receptor blockers: higher risks of severe acute respiratory syndrome coronavirus 2 infection but milder clinical manifestations? |
title_full | Patients taking angiotensin-converting enzyme inhibitors/angiotensin II type I receptor blockers: higher risks of severe acute respiratory syndrome coronavirus 2 infection but milder clinical manifestations? |
title_fullStr | Patients taking angiotensin-converting enzyme inhibitors/angiotensin II type I receptor blockers: higher risks of severe acute respiratory syndrome coronavirus 2 infection but milder clinical manifestations? |
title_full_unstemmed | Patients taking angiotensin-converting enzyme inhibitors/angiotensin II type I receptor blockers: higher risks of severe acute respiratory syndrome coronavirus 2 infection but milder clinical manifestations? |
title_short | Patients taking angiotensin-converting enzyme inhibitors/angiotensin II type I receptor blockers: higher risks of severe acute respiratory syndrome coronavirus 2 infection but milder clinical manifestations? |
title_sort | patients taking angiotensin-converting enzyme inhibitors/angiotensin ii type i receptor blockers: higher risks of severe acute respiratory syndrome coronavirus 2 infection but milder clinical manifestations? |
topic | Editorials |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7647493/ https://www.ncbi.nlm.nih.gov/pubmed/32804730 http://dx.doi.org/10.1097/CM9.0000000000000996 |
work_keys_str_mv | AT dengjielin patientstakingangiotensinconvertingenzymeinhibitorsangiotensiniitypeireceptorblockershigherrisksofsevereacuterespiratorysyndromecoronavirus2infectionbutmilderclinicalmanifestations AT jiangyunqiu patientstakingangiotensinconvertingenzymeinhibitorsangiotensiniitypeireceptorblockershigherrisksofsevereacuterespiratorysyndromecoronavirus2infectionbutmilderclinicalmanifestations AT guoyankai patientstakingangiotensinconvertingenzymeinhibitorsangiotensiniitypeireceptorblockershigherrisksofsevereacuterespiratorysyndromecoronavirus2infectionbutmilderclinicalmanifestations AT lihongliang patientstakingangiotensinconvertingenzymeinhibitorsangiotensiniitypeireceptorblockershigherrisksofsevereacuterespiratorysyndromecoronavirus2infectionbutmilderclinicalmanifestations |